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The purpose of this work was to investigate the use of an experimental CMOS (Complementary Metal-Oxide-
Semiconductor) APS (Active Pixel Sensor) for tracking of moving fiducial markers during radiotherapy. The
APS has an active area of 5.4 x 5.4 cm and maximum full frame read-out rate of 20 frame s−1, with the
option to read out a Region-Of-Interest (ROI) at an increased rate. It was coupled to a 4 mm thick ZnWO4
scintillator which provided a quantum efficiency (QE) of 8% for a 6 MV x-ray treatment beam. The APS
was compared with a standard iViewGT flat panel amorphous Silicon (a-Si) Electronic Portal Imaging Device
(EPID), with a QE of 0.34% and a frame-rate of 2.5 frame s−1. To investigate the ability of the two systems
to image markers, four gold cylinders of length 8 mm and diameter 0.8, 1.2, 1.6 and 2 mm were placed
on a motion platform. Images of the stationary markers were acquired using the APS at a frame-rate of
20 frame s−1, and a dose-rate of 143 MU min−1 to avoid saturation. EPID images were acquired at the
maximum frame-rate of 2.5 frame s−1, and a reduced dose-rate of 19 MU min−1to provide a similar dose
per frame to the APS. Signal-to-Noise Ratio (SNR) of the background signal and Contrast-to-Noise Ratio
(CNR) of the marker signal relative to the background were evaluated for both imagers at doses of 0.125 to
2 MU. Image quality and marker visibility was found to be greater in the APS with SNR ∼5 times greater
than in the EPID and CNR up to an order of magnitude greater for all four markers. To investigate the
ability to image and track moving markers the motion platform was moved to simulate a breathing cycle
with period 6 s, amplitude 20 mm and maximum speed 13.2 mm s−1. At the minimum integration time of
50 ms a tracking algorithm applied to the APS data found all four markers with a success rate of ≥92% and
positional error ≤90 µm. At an integration time of 400 ms the smallest marker became difficult to detect when
moving. The detection of moving markers using the a-Si EPID was difficult even at the maximum dose-rate
of 592 MU min−1 due to the lower QE and longer integration time of 400 ms. This work demonstrates that
a fast read-out, high QE APS may be useful in the tracking of moving fiducial markers during radiotherapy.
Further study is required to investigate the tracking of markers moving in 3-D in a treatment beam attenuated
by moving patient anatomy. This will require a larger sensor with ROI read-out to maintain speed and a
manageable data-rate.
Keywords: image-guided radiotherapy, fiducial markers, implanted markers, tracking, complementary metal-
oxide-semiconductor, active pixel sensor, electronic portal imaging
I. INTRODUCTION
Current radiotherapy techniques such as Intensity
Modulated Radiation Therapy (IMRT)1 and Volume15
Modulated Arc Therapy (VMAT)2,3 are able to deliver
highly conformal 3D dose distributions. However in the
case of moving tumours, such as those located in the
lung, the Planning Target Volume (PTV) is often de-
fined to include the position of the tumour at all times20
resulting in the irradiation of healthy tissue4. To amelio-
rate this effect and improve the therapeutic ratio infor-
mation describing the motion of the tumour may be used
to gate the treatment5, or possibly to adapt the delivery
to account for the motion6. The motion of the tumour25
a)Electronic mail: john.osmond@icr.ac.uk
may be determined from external skin markers7, breath
monitoring8, imaging of the MV treatment beam9, ad-
ditional keV imaging10,11 or implanted electromagnetic
markers12,13. The advantage of imaging the treatment
beam is that it requires no correlation between organ30
motion and external body motion and provides a beam’s
eye view of the tumour relative to the collimator. The
same image data can also be used to verify the beam
duration, field size and position of individual collima-
tor leaves providing a more comprehensive verification35
system14,15. However the high energy of the treatment
beam results in poor contrast between soft tissues of simi-
lar density necessitating the use of high density materials
such as bone or implanted Fiducial Markers (FMs) to in-
fer tumour position16,17. Furthermore the poor Quantum40
Efficiency (QE) and slow frame-rate inherent in the cur-
rent generation of MV Electronic Portal Imaging Devices
(EPIDs) can make the tracking of small moving features
2difficult, and their susceptibility to damage by MV radi-
ation results in failure after 1-2 years.45
Complementary Metal-Oxide Semiconductor (CMOS)
Active Pixel Sensors (APS) are commonly used in com-
mercial products such as digital cameras, mobile phones
and webcams and recent advancements have produced
sensors suitable for use in scientific applications such as50
medical imaging18–20. The addressable read-out archi-
tecture characteristic of APS sensors provides fast full
frame or Region-Of-Interest (ROI) read-out and allows
for the construction of small pixel and large area sensors
without the corresponding decrease in frame-rate associ-55
ated with a sequential read-out. The increased read-out
rate also allows the use of a more efficient scintillator
without an increase in the number of saturated pixels.
These properties combined with the relatively low cost,
low power consumption and improved radiation hardness60
means that APS sensors offer a potential advantage in
the imaging of small, low contrast moving FMs in an
MV treatment beam.
This study investigates the feasibility of using an APS
sensor with high QE and fast read-out to track moving65
FMs. The APS sensor used was a small prototype de-
veloped by the MI3 consortium21. It features an active
area of 5.4 x 5.4 cm and a maximum full frame rate of
20 frame s−1. Selecting a ROI within the frame increases
the read-out rate but 20 frame s−1 was considered suffi-70
cient as it would mean a marker moving at a clinically
relevant speed of up to 20 mm s−1 would travel less than
1 mm between frames. Gold markers of varying size were
moved in 1-D according to the Lujan approximation to
breathing motion and imaged using both the APS and75
an a-Si EPID. Image quality, marker visibility and the
success of a tracking algorithm were evaluated for both
technologies and a comparison made.
II. MATERIALS AND METHODS
A. Sensor and packaging80
The APS sensor used in this work is referred to as
the Large Area Sensor (LAS). The sensor specification
is detailed in Table I along with the specification of the
standard iViewGT a-Si EPID supplied with an Elekta
Synergy Linac (Elekta Oncolgy Systems, Crawley, UK).85
Significant modifications were required to make the
APS sensor suitable for use in an MV treatment beam.
Specifically, the sensor control and read-out electronics
were originally situated directly behind the active sen-
sor area and as such were at risk of damage from the90
incident x-ray radiation. The PCB containing these elec-
tronics was redesigned to move the electronics out of the
treatment beam, and a housing constructed to exclude
stray optical light whilst allowing air to flow past the
sensor to improve thermal stability. A 5.4 x 5.4 cm x 495
mm thick (3048 mg cm−2) ZnWO4 scintillator, formed
from two monolithic crystals 5.4 x 3.8 and 5.4 x 1.6 cm
Table I. Basic properties of the CMOS Active Pixel Sensor
(APS) and iViewGT amorphous Silicon (a-Si) Electronic Por-
tal Imaging Device (EPID).
APS a-Si EPID
Pixel size 40 × 40 µm 400 × 400 µm
Detector size 5.4 × 5.4 cm 41.0 × 41.0 cm
Readout rate 20 frame s−1 2.5 frame s−1
Scintillator Material ZnWO4 Gd2O2S
Scintillator Thickness 3048 mg cm−2 133 mg cm−2
Quantum Efficiency 8 % 0.34 %
in size and glued to a 1 mm glass substrate, was placed
directly on the sensor surface. A 1 mm copper plate was
placed on the scintillator, as in the a-Si EPID. A diagram100
of the modified sensor is shown in Fig 1.
A Xilinx Virtex-II Pro FPGA development board (Xil-
inx Ltd., Weybridge, UK) was used to generate the re-
quired APS control signals and transfer images to the
host computer via an optical transceiver. Operating pa-105
rameters were defined and images acquired using a Mat-
lab GUI (Mathworks Inc. Natwick, MA, USA) and image
data stored in 12-bit binary format.
The characteristics of the iViewGT have been mod-
elled using the EGSnrc/BEAMnrc Monte Carlo radiative110
transport package22–25. The model predicted that the
responsivity of a 6 MV treatment beam, i.e. the percent-
age of incident energy that produces a signal, is 0.34%.
The APS responsivity is dominated by the high QE of
the ZnWO4, which was calculated at 8% for the same115
beam (National Institute of Standards and Technology,
Gaithersburg, USA).
B. Experimental setup
The purpose of this experiment was to make a direct
comparison between an a-Si EPID and APS when used to120
image FMs moving according to breathing motion. Four
gold cylinders of length 8 mm and diameter 0.8, 1.2, 1.6
and 2 mm were fixed 5 mm apart in a low-density plas-
tic case. The markers were placed on a 10 mm thick
Carbon-fibre board attached to a 3-D motion-platform125
used in previous work26. The APS sensor was placed on
the treatment couch in the centre of the beam and with
the couch in its lowest position, providing a Source De-
tector Distance (SDD) of 130 cm. The motion platform
was placed such that the markers were 10 cm above the130
detector. The thin phantom and small object to detector
distances were chosen to allow comparison of the effects
of sensor characteristics such as pixel size, frame rate and
QE on the success of a marker tracking routine. The a-
Si EPID was mounted on the Linac gantry with a SDD135
fixed at 155 cm. For images acquired with the a-Si EPID
the motion-platform was placed such that the markers
were 10 cm above the detector. To evaluate the conse-
quences of the small difference in geometry the APS was
3(a)
(b)
Figure 1. Diagram (a) and photo (b) showing the APS with
redesigned packaging to allow use in an MV treatment beam.
In (b) the housing has been opened to reveal the APS.
repositioned to an SDD = 155 cm with the markers 10140
cm above. Static images of the markers were acquired
and shown to be similar in quality to those obtained at
an SDD = 130 cm.
To simulate the effect if in-vivo motion of the FMs the
motion-platform was programmed to move in 1-D accord-145
ing to the Lujan approximation to breathing motion:
z(t) = z0 −A cos
2n(
pit
τ
− θ) (1)
where z0 is the position at exhale, A is the peak-to-peak
amplitude of motion (20 mm), τ is the time period of the
breathing cycle (6 s), n determines the shape of the dis-
tribution (set to 2) and θ is the starting phase27. These150
parameters produced a breathing cycle with speeds in
the range 0 to 13.2 mm s−1 and a mean speed of v¯ = 6.6
mm s−1. The direction of motion and the axis through
the centre of the four markers were coaligned with the
vertical direction in the resulting images.155
C. Image acquisition and correction
To determine the optimum dose-rate for imaging us-
ing the APS a 6 MV treatment beam with a collimator
aperture of 4 x 4 cm at the isocentre was applied to the
motion-platform while it remained stationary. The opti-160
mum Pulse Repetition Frequency (PRF) was found to be
100, providing a dose rate of 143 MU min−1. Dose rates
greater than this were found to saturate a large number
of pixels at the maximum full frame-rate.
A sequence of 240 frames were acquired with the APS165
at 20 frame s−1 over 12 s. A further 240 frames, equiva-
lent to two complete breathing cycles were acquired un-
der the same conditions but with the motion-platform
moving. The procedure was repeated with the a-Si EPID
running at its maximum frame-rate of 2.5 frame s−1 and170
using two dose-rates. The first was the maximum PRF
of 400 (562 MU min−1), and the second used a PRF of
12.5 (19 MU min−1) which provided a dose within each
frame comparable to the APS.
To evaluate Dark Fixed Pattern Noise (DFPN) a se-175
quence of 240 frames were acquired with no illumination
of the sensor. The mean signal was calculated for each
pixel to provide a single dark frame Id(x, y). To remove
the effect of spatial non-uniformity in either the shape of
the treatment beam or the gain of the sensor, a sequence180
of open images were acquired with the treatment beam
applied as before and the markers removed from the field
but the motion-platform and Carbon-fibre board left in
place. A mean was taken to provide a single open field
image Iof(x, y). Images of the markers acquired using185
both instruments were then corrected using the relation:
Ic(x, y) =
I(x, y)− Id(x, y)
Iof(x, y)− Id(x, y)
(2)
where I(x, y) is the original image and Ic(x, y) is the cor-
rected image.
Previous characterisation of the APS sensor has found
certain columns to exhibit a small number of spiking pix-190
els with an unusually high signal for a short period of
time28. The column structure is a product of the man-
ufacturing process whereby a small number of photo-
lithography masks are tiled to form the sensor. These
spiking pixels do not significantly degrade the image195
quality but make the standard deviation of pixel values
an inaccurate estimator of the image noise. Spiking pix-
els were removed by calculating the Inter-Quartile Range
(IQR) of all pixel values within each sequence of frames
and excluding pixels with a signal greater than the third200
quartile plus three times the IQR.
Images acquired with both the APS and a-Si EPID
were found to contain bright vertical bars which moved
uniformly across the sensor from frame to frame. These
bars were a consequence of the sensors operating asyn-205
crhonously with the treatment machine pulse generator.
A horizontal profile of the bright bars was derived by cal-
culating the mean value within each column in a single
frame. Each row in the frame was then divided by this
mean profile to remove the bars.210
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Figure 2. Four cylindrical gold markers of diameter 0.8, 1.2, 1.6 and 2 mm imaged using the 6 MV treatment beam. The top
row shows images acquired using the APS at doses of 0.125 to 2 MU frame−1, and the bottom row shows the same acquired
using the a-Si EPID.
D. Image quality and marker visibility
To investigate the effect of dose on image quality and
marker visibility two spatial regions were defined within
the stationary marker frame sequence. The first region
was defined so as to exclude the markers and the signal-215
to-noise ratio (SNR) in this region calculated using the
relation:
SNR =
I¯
σI
(3)
where I¯ is the mean signal value and σI is the standard
deviation. A second region containing the markers was
selected and a vertical profile calculated by taking the220
mean row values within this region. The attenuation pro-
files of individual markers within the vertical profile were
used to manually identify the positions of the stationary
markers. To evaluate marker visibility a contrast-to-noise
ratio (CNR) was calculated for each marker using the re-225
lation:
CNR =
Imax − Imin
σI
(4)
where Imin is the minimum value at the centre of each
marker attenuation profile and Imax is the maximum
value in the profile within 5 mm of the minimum position.
Frames were then added together in groups of 1, 2... 20230
to simulate frame-doses of 0.125, 0.25... 2 MU frame−1,
and SNR and CNR recalculated.
E. Automatic marker tracking
To investigate the effect of marker speed and sensor in-
tegration time on QE and the visibility of moving mark-235
ers, two regions were defined in each frame of the moving
marker frame sequence. The first region excluded the
markers and was used to estimate frame noise, and the
second contained the markers at all positions. A verti-
cal profile was calculated for each frame from the mean240
row values within the marker region as before. The pro-
file was then convolved with a kernel derived from the
expected cross section of each marker in turn. The posi-
tion of the four minima in the resulting convolved profiles
were taken as the estimated marker positions. CNR was245
calculated for each marker at each position using Eqn 4.
The errors in the measured marker positions were derived
by plotting the position of each marker against time and
5comparing with the Lujan model used to program the
motion-platform. The standard deviation in the residu-250
als from the programmed trajectory were used to esti-
mate the error and the differential of the trajectory used
to estimate marker speed. If the measured position of
the marker was >2 mm from the expected position, the
tracking algorithm was said to have failed, and CNR was255
calculated at the expected position of the marker.
Frames were then added together in groups of 1, 2...
20 to simulate integration times of 50, 100... 1000 ms in
the APS, and the automatic marker tracking repeated.
The distance travelled by the marker within each frame260
was estimated from the marker speed and the integration
time for each frame. The process was repeated for the
a-Si EPID.
III. RESULTS AND DISCUSSION
A. Image quality and marker visibility265
Fig 2 shows images of all four markers acquired with
both the APS and a-Si EPID and using doses of 0.125,
0.25... 2 MU. It appears that the APS sensor provides a
far superior resolution and noise at comparable dose. The
smallest marker is visible to the human eye, an indicator270
of its visibility to an automatic tracking algorithm, at
a dose of ∼0.25 MU in the APS images but requires a
much larger dose of ∼1 MU before it is visible in the a-Si
EPID.
Fig 3 shows the SNR vs Dose in the marker-free re-275
gion of the stationary sequence for both the APS and a-Si
EPID sensors. The APS provides a significantly superior
image quality at comparable dose as expected from its
superior QE. In addition the a-Si EPID pixels are 100
times greater in area than those in the APS leading to280
an averaging of signal and a corresponding reduction in
noise at the expense of resolution. To estimate the reduc-
tion in noise due the increase in pixel area, APS pixels
were added together to create virtual pixels of 400 x 400
µm and SNR recalculated. An estimate of SNR as a285
function of dose for the APS sensor but accounting for
the difference in scintillator (by scaling QE) and pixel
size is included as a dotted line in Fig 3 and lies below
that for the a-Si EPID, suggesting that the increase in
image quality is the result of the increased scintillator290
efficiency. However the use of more efficient scintilla-
tor with the APS sensor is possible due to the increased
frame-rate.
Fig 4 shows CNR for the four stationary markers in
the APS (a) and a-Si EPID (b) images as a function295
of dose. Both plots show the same range in dose and
the range in CNR is ten times greater in the APS plot.
The APS sensor provides a superior marker visibility at
a comparable dose.
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Figure 3. Square of the Signal-to-Noise Ratio (SNR2) in
the APS and a-Si EPID as a function of dose. The APS′
line corresponds to the APS result scaled to account for the
difference in quantum efficiency and pixel size.
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Figure 4. Contrast-to-Noise Ratio (CNR) of the four static
markers as a function of dose for the APS (a) and a-Si EPID
(b).
6B. Automatic marker tracking300
Fig 5 shows the position of the four markers whilst
moving, as determined by an automatic tracking algo-
rithm applied to the APS data as a function of time.
Symbols represent the measured positions, and the lines
correspond to the positions expected from the input to305
the motion-platform. The positions are shown for two
integration times, 100 ms (a) corresponding to twice the
minimum integration time of the APS and 400 ms (b)
equivalent to the minimum integration time of the a-Si
EPID. Data corresponding to the minimum APS inte-310
gration time of 50 ms is not shown as the quantity of
measurements makes the resulting plot difficult to inter-
pret. At ti = 100 ms integration time almost all markers
are successfully located at all times and the measured
positions agree well with expectation. For 400 ms only315
the 2 mm marker is accurately located at all times. The
smaller markers are well located while stationary but are
increasingly poorly located with decreasing marker size
when moving. This may be the result of a marker trav-
elling further in one integration time and spreading its320
attenuation signal over a larger number of pixels with a
corresponding drop in CNR, despite the drop in noise
resulting from the longer integration time. This would
make it more difficult to both locate the marker amongst
the noise, and accurately determine the centre of its at-325
tenuation profile.
To further illustrate the effect of integration time on
the effectiveness of the automatic tracking algorithm as
applied to the APS data, Fig 6(a) shows the success rate
as a function of integration time and for each of the four330
markers. Fig 6(b) shows the error in the measured po-
sition. The solid vertical lines represent the minimum
integration times of the APS and a-Si EPID. At the APS
integration time the three largest markers are located
with a success rate of 100%, and error of 40, 49 and 59335
µm in decreasing order of marker size, which is close to
the pixel size of the APS (40 µm). The smallest 0.8 mm
marker is detected with a success rate of 92% and error of
90 µm. However at the a-Si EPID minimum integration
time the success rate has dropped below 100% for all four340
markers and the two smallest markers are located with
a success rate of 71% and 46%, and errors of 0.54 and
0.41 mm. All errors are small relative to the breathing
amplitude of 20 mm suggesting that success rate may be
a more appropriate indicator of the quality of the auto-345
matic tracking.
The relationship between CNR and the success rate in
tracking is shown in Fig 7. Success is calculated using all
four markers imaged at all integration times and mea-
surements are grouped according to CNR into twenty350
evenly spaced bins, each containing >20 markers.
Fig 8 shows the effect of marker speed and integration
time on detectability. The x-axis (∆s) denotes the dis-
tance a marker travels in a single frame. Markers were
grouped together according to ∆s into 7 evenly spaced355
bins between 0 and 3.5 mm. The mean and standard
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Figure 5. Positions of the four markers as a function of time.
The symbols represent the marker positions as found by the
tracking algorithm applied to the APS data and the solid lines
represent the expected positions. Fig (a) corresponds to an
integration time of 100 ms and (b) to 400 ms.
deviation of CNR within these bins is shown. CNR ap-
pears to drop with increasing ∆s for all four markers and
the smallest marker only exhibits a CNR significantly
above 1 for ∆s below 1.5 mm. Given a maximum marker360
speed of 13.2 mm s−1, the longest integration time re-
quired to limit travel to below 1.5 mm is 114 ms, corre-
sponding to a frame-rate of 8.8 frame s−1.
When applied to the a-Si EPID data the tracking al-
gorithm was unable to locate the moving markers except365
in the case of stationary or very slow moving markers
imaged using the minimum integration time of 400 ms.
Fig 9 shows two typical marker attenuation profiles for
both the slow moving region of the breathing cycle, and
at the mean speed of 6.6 mm s−1. Marker positions can370
be easily derived from the slow moving profile, however
the speed of the marker combined with the relatively long
integration time of the a-Si EPID results in the profiles of
the four moving markers blurring together and appearing
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Figure 6. The success of the tracking algorithm applied to
the APS data for the four markers as a function of integration
time. Fig (a) shows the percentage of markers found to be
within 2 mm of the expected position and (b) shows the error
in the position of the marker. The vertical lines correspond
to the minimum integration time of the APS and a-Si EPID.
indistinct.375
IV. CONCLUSIONS
This work has demonstrated the use of a high quan-
tum efficiency, fast readout CMOS active pixel sensor
for imaging moving fiducial markers during radiother-
apy. The APS can image markers with greater contrast-380
to-noise ratio than the conventional flat panel a-Si EPID
at an equivalent dose. At its fastest frame-rate of 20
frame s−1 the APS can track the smallest 0.8 mm marker
when moving at up to 13.2 mm s−1 with a success rate
of 92% and a positional error of 90 µm. The three larger385
makers are located with a success rate of 100% and po-
sitional error of 40-60 µm at the same frame-rate. The
slow frame-rate of the a-Si EPID results in an attenua-
tion profile that is too blurred to determine the positions
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Figure 7. Success of the tracking algorithm applied to the
APS data as a function of CNR. Success is the percentage of
markers found to be within 2 mm of their expected position.
Markers are grouped according to CNR in 20 evenly spaced
bins.
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Figure 8. CNR of the four markers as a function of distance
travelled within an APS frame. Values are averaged within 7
evenly spaced bins containing >20 values. Error-bars corre-
spond to 1 standard deviation.
of moving markers. The preliminary results presented390
here were obtained with markers moving in 1-D, placed
close to the imagers and with no intervening absorber.
This allowed for a direct comparison between the per-
formance of the two imaging systems. To better repli-
cate in-vivo conditions the markers should be moved in395
3-D and imaged with an intervening moving anatomical
phantom and this will be the subject of future work. The
APS used here is an experimental model and too small
for routine clinical use (5.4 x 5.4 cm). A larger sensor
(12 x 12 cm) is under development that will allow ROI400
readout at 45 frame s−1.
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Figure 9. Attenuation profiles of the four markers moving at
two speeds using the a-Si EPID. Images were acquired using
the maximum Pulse Repetition Frequency of 400 s−1 and the
minimum integration time of 400 ms.
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